ClinicalTrials.Veeva

Menu

Liquid Biopsy in Lung Cancer

Samsung Medical Center logo

Samsung Medical Center

Status

Completed

Conditions

Lung Cancer (Diagnosis)
Circulating Tumor Cell

Study type

Observational

Funder types

Other

Identifiers

NCT03479099
2018-01-081

Details and patient eligibility

About

The purpose of this study is to assess clinical utility of combined circulating tumor cell (CTC) and circulating tumor DNA (ctDNA) in the diagnosis of primary lung cancer.

Full description

The peripheral blood and tumor tissue samples are collected from the participants.CTC and ctDNA are analyzed from the blood samples.

Enrollment

111 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with histology-proven lung cancer or a clinical suspicion of lung cancer
  • Age >=18, < 80 years
  • No previous history of cancer treatment within 5 years
  • Patients who agree to participate

Exclusion criteria

  • Patients who have been diagnosed with malignancy within 5 years
  • Patients with previous history of lung cancer
  • Patients who have uncontrolled coagulopathy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems